However, despite the noticeable reduction in tumor burden at day 14 in mice with Ripk4 KD, the tumors that persisted continued to grow, leading to the mice eventually succumbing to the tumor burden in their lungs (Fig. 3G). The gene discussed is RIPK4; the disease is neoplasm.